{"id":4331,"date":"2016-01-26T17:11:45","date_gmt":"2016-01-27T01:11:45","guid":{"rendered":"https:\/\/wealththrunutrition.com\/?page_id=4331"},"modified":"2020-05-15T00:25:55","modified_gmt":"2020-05-15T00:25:55","slug":"studies-articles","status":"publish","type":"page","link":"https:\/\/wealththrunutrition.com\/uk\/studies-articles\/","title":{"rendered":"Reliv Studies and Articles"},"content":{"rendered":"
All<\/a>\/<\/span><\/div>
Cardiovascular<\/a>\/<\/span><\/div>
Inflammation<\/a>\/<\/span><\/div>
Other<\/a>\/<\/span><\/div>
Weight Loss<\/a>\/<\/span><\/div><\/div>\n

A team of scientists in the Philippines led by Jorge Sison<\/strong>, MD, conducted a study to determine the effects of Reliv Now<\/a> and FibRestore<\/a> in reducing major risk factors for cardiovascular disease.
\nThe facts:<\/strong>
\n\u2022 Cardiovascular diseases rank number one in causing death globally.
\n\u2022 Lipid abnormalities like high cholesterol, triglycerides, LDL (\u201cbad cholesterol\u201d) and HDL (\u201cgood cholesterol\u201d) are major risk factors for cardiovascular disease.
\n\u2022 Soy and fibers have been proven to help improve lipid abnormalities and therefore, benefit health.
\nThe results:<\/strong>
\nReliv Now and FibRestore\u2026
\n\u2022 Reduced average cholesterol by 14%
\n\u2022 Reduced average LDL by 18% and 8%, respectively
\n\u2022 Reduced average triglycerides by 1.2% and 12.4%, respectively
\n\u2022 Reduced average uric acid by 10.4% and 16.7%, respectively
\n\u2022 Produced greater reduction in cholesterol and triglycerides among diabetic and\/or overweight individuals
\nFull Study<\/a> (PDF)
\nThese statements have not been evaluated by the Food and Drug Administration. Reliv products are not intended to diagnose, treat, cure or prevent any disease.<\/em><\/p>\n<\/div><\/div><\/div><\/section>\n

A recent study of pigs supplemented daily with Reliv Now\u00ae<\/a> and LunaRich X\u2122 for eight weeks showed significant improvement in key biomarkers associated with cardiovascular and metabolic health.<\/p>\n

Test subjects recorded a decrease in weight gain and a 65% reduction in free fatty acid (FFA) levels, a biomarker associated with obesity and metabolic syndrome.\u00a0The decrease in FFA levels was accompanied by coordinate increases in plasma levels of the hormones leptin (+64%) and adiponectin (+60%). Leptin signals the brain when the body had enough food, producing the feeling of fullness. Adiponectin (ADP) is a hormone from fat cells that controls energy metabolism, increases insulin sensitivity and supports weight loss. The two hormones perform complementary actions and can have additive effects on weight management.<\/p>\n

Study Results<\/a><\/p>\n<\/div><\/div><\/div><\/section>\n

This study demonstrates that lunasin<\/a> can effectively suppress allergic airway inflammation in two murine models of asthma.<\/p>\n<\/div><\/div><\/div><\/section>\n

Oral Administration of CardioAid and Lunasin Alleviates Liver Damage<\/a> in a High-Fat Diet Nonalcoholic Steatohepatitis Model.<\/p>\n<\/div><\/div><\/div><\/section>\n

Lunasin\u2019s Heart Health Studies<\/strong>
\nRGD-peptide lunasin inhibits Akt-mediated NF-\u03baB activation in human macrophages through interaction with the \u03b1V\u03b23 integrin.<\/a>
\nEndocytic mechanism of internalization of dietary peptide lunasin into macrophages in inflammatory condition associated with cardiovascular disease<\/a>.
\nMeta-analysis of the effects of soy protein containing isoflavones on the lipid profile.<\/a><\/p>\n<\/div><\/div><\/div><\/section>\n